Biopharma Update on the Novel Coronavirus: June 29

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated […]

Clinical Catch-Up: June 22-26

It was a busy week for clinical trial updates. Here’s a look. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and rest of […]

Coronavirus (COVID-19) Update: Daily Roundup June 29, 2020

Coronavirus (COVID-19) Update: Daily Roundup Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and rest of the world. – A list of more […]

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

FDA approves Keytruda for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges […]

ChargePoint butterfly valve safely handles APIs

The companyâs PharmaSafe containment split butterfly valve is designed for safe handling of non-sterile API and formulation ingredients. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and […]